Literature DB >> 9164937

A selective inhibitor of dipeptidyl peptidase I impairs generation of CD8+ T cell cytotoxic effector function.

D L Thiele1, M J McGuire, P E Lipsky.   

Abstract

CTL express high levels of dipeptidyl peptidase I (DPPI), a granule thiol protease able to convert the zymogen precursors of granzymes A and B into active proteases. In the present studies, the effects of specific inhibition of DPPI on generation of CTL effector functions were examined. When T cell DPPI activity was inhibited by >95% throughout 5-day MLC, a significant reduction in the generation of CD8+ T cell BLT esterase activity (<30% of control) and cytolytic activity (<10% of control) was observed. DPPI inhibition during the second to fourth days of 5-day MLC also was associated with reduced proliferation of CD8+ T cells, but had no effect on CD4+ T cell proliferation or IL-2 production by either population. CTL generated in the continuous presence of DPPI inhibition also exhibited impaired lysis of anuclear erythrocyte targets and diminished killing of nucleated targets by perforin-independent pathways. In contrast, inhibition of DPPI during only the last 24 h of 5-day MLC was associated only with reduced generation of BLT esterase activity and reduced lysis of nucleated targets by perforin-dependent pathways. Repeated or delayed inhibition of DPPI in MLC containing granzyme B-deficient responder cells also impaired generation of cytotoxic activity. These results indicate that DPPI or other DPPI-like protease activities not only are required for the activation of granzymes, but also play a role in the expansion and differentiation of full CD8+ T cell cytolytic activity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9164937

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

1.  Discovery of novel cyanamide-based inhibitors of cathepsin C.

Authors:  Dramane Lainé; Michael Palovich; Brent McCleland; Emilie Petitjean; Isabelle Delhom; Haibo Xie; Jianghe Deng; Guoliang Lin; Roderick Davis; Anais Jolit; Neysa Nevins; Baoguang Zhao; Jim Villa; Jessica Schneck; Patrick McDevitt; Robert Midgett; Casey Kmett; Sandra Umbrecht; Brian Peck; Alicia Bacon Davis; David Bettoun
Journal:  ACS Med Chem Lett       Date:  2010-11-10       Impact factor: 4.345

2.  Dipeptidyl peptidase I is required for the processing and activation of granzymes A and B in vivo.

Authors:  C T Pham; T J Ley
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

3.  Granzyme C supports efficient CTL-mediated killing late in primary alloimmune responses.

Authors:  Yonas Getachew; Heather Stout-Delgado; Bonnie C Miller; Dwain L Thiele
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

4.  Cathepsin L inhibition prevents murine autoimmune diabetes via suppression of CD8(+) T cell activity.

Authors:  Akiko Yamada; Naozumi Ishimaru; Rieko Arakaki; Nobuhiko Katunuma; Yoshio Hayashi
Journal:  PLoS One       Date:  2010-09-22       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.